Hepatitis B vaccines are highly effective and safe and have been incorporated into national immunization programs in over 150 countries. The major humoral immune response is to the common a determinant of the surface antigen protein of the virus. Approximately 5-10% of healthy immunocompetent subjec
β¦ LIBER β¦
Hepatitis B vaccines: Protective efficacy and therapeutic potential
β Scribed by M.-L. Michel; P. Tiollais
- Book ID
- 116822037
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 419 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0369-8114
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Protective efficacy, immunotherapeutic p
β
Jane N. Zuckerman
π
Article
π
2005
π
John Wiley and Sons
π
English
β 99 KB
Protective efficacy of hepatitis B vacci
β
Francis E. AndrΓ©; Arie J. Zuckerman
π
Article
π
1994
π
John Wiley and Sons
π
English
β 890 KB
## Abstract A literature search was carried out to investigate the factors that influence the protective efficacy (PE) of hepatitis B vaccines when given to neonates of hepatitis B surface antigen and __e__ antigen positive mothers. Hepatitis B vaccines with either high or low antigen doses are ver
Protective efficacy of hepatitis B vacci
β
MichaelC. Kew
π
Article
π
1995
π
The Lancet
π
English
β 319 KB
Persistence of anti-HBs and protective e
β
KEN YOSHIDA; SHIGETOSHI FUJIYAMA; TATSUO SATO
π
Article
π
1990
π
John Wiley and Sons
π
English
β 297 KB
Protective immunity after hepatitis B va
β
Ayman Eldesoky; Youssef Mosaad; Yahia Zakria; Samah Hamdy
π
Article
π
2009
π
Elsevier
π
English
β 189 KB
Design of therapeutic vaccines: hepatiti
β
Sarah Kutscher; Tanja Bauer; Claudia Dembek; Martin Sprinzl; Ulrike Protzer
π
Article
π
2011
π
Wiley (Blackwell Publishing)
π
English
β 354 KB